Page last updated: 2024-11-05

trientine and Breast Cancer

trientine has been researched along with Breast Cancer in 2 studies

Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lespérance, M1
Roy, J1
Djiemeny Ngueta, A1
Maltais, R1
Poirier, D1
Lixia, G1
Fei, Y1
Jiajia, J1
Jianhui, L1

Other Studies

2 other studies available for trientine and Breast Cancer

ArticleYear
Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases.
    Steroids, 2021, Volume: 172

    Topics: 17-Hydroxysteroid Dehydrogenases; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Enzym

2021
Triethylene tetramine, a novel ligand of G-quadruplex, induces senescence of MCF-7 cells.
    Biotechnology letters, 2008, Volume: 30, Issue:1

    Topics: Breast Neoplasms; Cell Line, Tumor; Cellular Senescence; Dose-Response Relationship, Drug; G-Quadrup

2008